What is PsyCare?
PsyCare, Inc. is a prominent psychiatry practice dedicated to the treatment of depression, obsessive-compulsive disorder (OCD), and smoking cessation. Leveraging innovative therapies such as Brainsway Deep TMS Therapy and Spravato, the practice serves patients across West Virginia and Pennsylvania. PsyCare is committed to advancing mental health care through ongoing research and offers a hybrid model of both in-person and telehealth appointments. Their team of qualified professionals focuses on supporting individuals in overcoming a range of mental health challenges.
How much funding has PsyCare raised?
PsyCare has raised a total of $721K across 2 funding rounds:
Debt
$350K
Debt
$371K
Debt (2020): $350K with participation from PPP
Debt (2021): $371K led by PPP
Key Investors in PsyCare
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for PsyCare?
The recent major strategic investment indicates a pivotal growth phase for PsyCare. This capital infusion is likely to fuel expansion of their service offerings, potentially broadening their geographic reach or enhancing their technological capabilities in delivering advanced psychiatric treatments. The company's focus on research and innovative therapies positions it for continued leadership in the mental health sector, with future developments expected to further solidify its market presence.
See full PsyCare company page
